Literature DB >> 23660517

Progressive impairment of muscle regeneration in muscleblind-like 3 isoform knockout mice.

Michael G Poulos1, Ranjan Batra, Moyi Li, Yuan Yuan, Chaolin Zhang, Robert B Darnell, Maurice S Swanson.   

Abstract

The muscleblind-like (MBNL) genes encode alternative splicing factors that are essential for the postnatal development of multiple tissues, and the inhibition of MBNL activity by toxic C(C)UG repeat RNAs is a major pathogenic feature of the neuromuscular disease myotonic dystrophy. While MBNL1 controls fetal-to-adult splicing transitions in muscle and MBNL2 serves a similar role in the brain, the function of MBNL3 in vivo is unknown. Here, we report that mouse Mbnl3, which encodes protein isoforms that differ in the number of tandem zinc-finger RNA-binding motifs and subcellular localization, is expressed primarily during embryonic development but also transiently during injury-induced adult skeletal muscle regeneration. Mbnl3 expression is required for normal C2C12 myogenic differentiation and high-throughput sequencing combined with cross-linking/immunoprecipitation analysis indicates that Mbnl3 binds preferentially to the 3' untranslated regions of genes implicated in cell growth and proliferation. In addition, Mbnl3ΔE2 isoform knockout mice, which fail to express the major Mbnl3 nuclear isoform, show age-dependent delays in injury-induced muscle regeneration and impaired muscle function. These results suggest that Mbnl3 inhibition by toxic RNA expression may be a contributing factor to the progressive skeletal muscle weakness and wasting characteristic of myotonic dystrophy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23660517      PMCID: PMC3736872          DOI: 10.1093/hmg/ddt209

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  53 in total

Review 1.  Mechanisms of RNA-mediated disease.

Authors:  Jason R O'Rourke; Maurice S Swanson
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

2.  Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein.

Authors:  S Michalowski; J W Miller; C R Urbinati; M Paliouras; M S Swanson; J Griffith
Journal:  Nucleic Acids Res       Date:  1999-09-01       Impact factor: 16.971

3.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

4.  Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells.

Authors:  Majid Fardaei; Mark T Rogers; Helena M Thorpe; Kenneth Larkin; Marion G Hamshere; Peter S Harper; J David Brook
Journal:  Hum Mol Genet       Date:  2002-04-01       Impact factor: 6.150

5.  Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins.

Authors:  Eric T Wang; Neal A L Cody; Sonali Jog; Michela Biancolella; Thomas T Wang; Daniel J Treacy; Shujun Luo; Gary P Schroth; David E Housman; Sita Reddy; Eric Lécuyer; Christopher B Burge
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

6.  Evidence for instability of mRNAs containing AUUUA motifs mediated through translation-dependent assembly of a > 20S degradation complex.

Authors:  S Savant-Bhonsale; D W Cleveland
Journal:  Genes Dev       Date:  1992-10       Impact factor: 11.361

7.  Identification of MBNL1 and MBNL3 domains required for splicing activation and repression.

Authors:  Ioannis Grammatikakis; Young-Hwa Goo; Gloria V Echeverria; Thomas A Cooper
Journal:  Nucleic Acids Res       Date:  2010-11-24       Impact factor: 16.971

8.  New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats.

Authors:  François-Xavier Laurent; Alain Sureau; Arnaud F Klein; François Trouslard; Erwan Gasnier; Denis Furling; Joëlle Marie
Journal:  Nucleic Acids Res       Date:  2011-12-09       Impact factor: 16.971

9.  MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing.

Authors:  Emily S Goers; Jamie Purcell; Rodger B Voelker; Devika P Gates; J Andrew Berglund
Journal:  Nucleic Acids Res       Date:  2010-01-13       Impact factor: 16.971

10.  Genome-wide survey and expression profiling of CCCH-zinc finger family reveals a functional module in macrophage activation.

Authors:  Jian Liang; Wenjun Song; Gail Tromp; Pappachan E Kolattukudy; Mingui Fu
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

View more
  38 in total

1.  Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease.

Authors:  Ranjan Batra; Konstantinos Charizanis; Mini Manchanda; Apoorva Mohan; Moyi Li; Dustin J Finn; Marianne Goodwin; Chaolin Zhang; Krzysztof Sobczak; Charles A Thornton; Maurice S Swanson
Journal:  Mol Cell       Date:  2014-09-25       Impact factor: 17.970

Review 2.  Repeat-associated RNA structure and aberrant splicing.

Authors:  Melissa A Hale; Nicholas E Johnson; J Andrew Berglund
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-07-16       Impact factor: 4.490

3.  Mechanistic determinants of MBNL activity.

Authors:  Łukasz J Sznajder; Michał Michalak; Katarzyna Taylor; Piotr Cywoniuk; Michał Kabza; Agnieszka Wojtkowiak-Szlachcic; Magdalena Matłoka; Patryk Konieczny; Krzysztof Sobczak
Journal:  Nucleic Acids Res       Date:  2016-10-12       Impact factor: 16.971

Review 4.  Biology of RNA Surveillance in Development and Disease.

Authors:  Brice Laffleur; Uttiya Basu
Journal:  Trends Cell Biol       Date:  2019-02-10       Impact factor: 20.808

5.  MBNL1 overexpression is not sufficient to rescue the phenotypes in a mouse model of RNA toxicity.

Authors:  Ramesh S Yadava; Yun K Kim; Mahua Mandal; Karunasai Mahadevan; Jordan T Gladman; Qing Yu; Mani S Mahadevan
Journal:  Hum Mol Genet       Date:  2019-07-15       Impact factor: 6.150

Review 6.  Disruption of RNA Metabolism in Neurological Diseases and Emerging Therapeutic Interventions.

Authors:  Julia K Nussbacher; Ricardos Tabet; Gene W Yeo; Clotilde Lagier-Tourenne
Journal:  Neuron       Date:  2019-04-17       Impact factor: 17.173

7.  MBNL Sequestration by Toxic RNAs and RNA Misprocessing in the Myotonic Dystrophy Brain.

Authors:  Marianne Goodwin; Apoorva Mohan; Ranjan Batra; Kuang-Yung Lee; Konstantinos Charizanis; Francisco José Fernández Gómez; Sabiha Eddarkaoui; Nicolas Sergeant; Luc Buée; Takashi Kimura; H Brent Clark; Joline Dalton; Kenji Takamura; Sebastien M Weyn-Vanhentenryck; Chaolin Zhang; Tammy Reid; Laura P W Ranum; John W Day; Maurice S Swanson
Journal:  Cell Rep       Date:  2015-08-06       Impact factor: 9.423

8.  NKX2-5, a modifier of skeletal muscle pathology due to RNA toxicity.

Authors:  Jordan T Gladman; Ramesh S Yadava; Mahua Mandal; Qing Yu; Yun K Kim; Mani S Mahadevan
Journal:  Hum Mol Genet       Date:  2014-08-28       Impact factor: 6.150

9.  The zinc finger domains in U2AF26 and U2AF35 have diverse functionalities including a role in controlling translation.

Authors:  Olga Herdt; Stefan Reich; Jan Medenbach; Bernd Timmermann; Didrik Olofsson; Marco Preußner; Florian Heyd
Journal:  RNA Biol       Date:  2020-03-01       Impact factor: 4.652

10.  Correction of Glycogen Synthase Kinase 3β in Myotonic Dystrophy 1 Reduces the Mutant RNA and Improves Postnatal Survival of DMSXL Mice.

Authors:  Mei Wang; Wen-Chin Weng; Lauren Stock; Diana Lindquist; Ana Martinez; Genevieve Gourdon; Nikolai Timchenko; Mike Snape; Lubov Timchenko
Journal:  Mol Cell Biol       Date:  2019-10-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.